MedTrace Logo

Breath Test to Predict Breast Cancer and Outcome of Mammography

NCT04755829 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2021-02-16

No results posted yet for this study

Summary

To validate a breath test that predicts risk of breast cancer and an abnormal mammogram.

Conditions

Interventions

DEVICE

BreathX test for breath VOCs

Breath samples are collected into an ultra-clean bag and breath VOCs are analyzed with GC-SAW.

Sponsors & Collaborators

  • Mount Vernon Cancer Centre

    collaborator UNKNOWN

  • Zuyderland Medical Centre

    collaborator OTHER

  • University of Erlangen-Nürnberg

    collaborator OTHER

  • Menssana Research, Inc.

    lead INDUSTRY

Principal Investigators

  • Alexandra Tenovici · Frimley Health NHS Foundation Trust

  • Marc Lobbes, MD · Zuyderland Medical Center

  • Peter Fasching, MD · University of Erlangen-Nürnberg

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-31
Primary Completion
2023-03-31
Completion
2023-03-31

Countries

  • Germany
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04755829 on ClinicalTrials.gov